CD5 and B-cell chronic lymphocytic leukemia: It was therefore of interest to investigate whether the largely increased CD5+ B1a cell population and the higher BCR signaling in B1a cells of Siglec‐G‐deficient (Siglecg−/−) mice might promote or enhance the development of CLL‐like disease in mice.